Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LINAGLIPTIN Cause Chronic kidney disease? 84 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Chronic kidney disease have been filed in association with LINAGLIPTIN (Linagliptin and metformin hydrochloride). This represents 1.1% of all adverse event reports for LINAGLIPTIN.

84
Reports of Chronic kidney disease with LINAGLIPTIN
1.1%
of all LINAGLIPTIN reports
10
Deaths
58
Hospitalizations

How Dangerous Is Chronic kidney disease From LINAGLIPTIN?

Of the 84 reports, 10 (11.9%) resulted in death, 58 (69.0%) required hospitalization, and 7 (8.3%) were considered life-threatening.

Is Chronic kidney disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LINAGLIPTIN. However, 84 reports have been filed with the FAERS database.

What Other Side Effects Does LINAGLIPTIN Cause?

Blood glucose increased (804) Dyspnoea (571) Dizziness (529) Pruritus (527) Nausea (525) Diarrhoea (509) Vomiting (465) Fatigue (464) Malaise (457) Arthralgia (446)

What Other Drugs Cause Chronic kidney disease?

OMEPRAZOLE (35,759) ESOMEPRAZOLE (35,281) LANSOPRAZOLE (32,517) PANTOPRAZOLE (28,127) DEXLANSOPRAZOLE (15,973) EMTRICITABINE\TENOFOVIR DISOPROXIL (10,248) TENOFOVIR DISOPROXIL (7,230) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (5,861) RABEPRAZOLE (4,773) ESOMEPRAZOLE\NAPROXEN (2,714)

Which LINAGLIPTIN Alternatives Have Lower Chronic kidney disease Risk?

LINAGLIPTIN vs LINAGLIPTIN\METFORMIN LINAGLIPTIN vs LINCOMYCIN LINAGLIPTIN vs LINEZOLID LINAGLIPTIN vs LINZESS LINAGLIPTIN vs LIORESAL

Related Pages

LINAGLIPTIN Full Profile All Chronic kidney disease Reports All Drugs Causing Chronic kidney disease LINAGLIPTIN Demographics